Clinical Trials Browser

Phase 3 × Has results × Risedronic Acid × Clear all

NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

Phase 3 Completed

72 enrolled 8 charts

LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00216060 2016-05-26

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Phase 3 Terminated

63 enrolled 19 charts

Prostatic Neoplasms